Solidification to improve the biopharmaceutical performance of SEDDS: Opportunities and challenges

Paul Joyce, Tahnee J Dening, Tahlia R Meola, Hayley B Schultz, René Holm, Nicky Thomas, Clive A. Prestidge

Research output: Contribution to journalJournal articleResearchpeer-review

Abstract

Self-emulsifying drug delivery systems (SEDDS) offer potential for overcoming the inherent slow dissolution and poor oral absorption of hydrophobic drugs by retaining them in a solubilised state during gastrointestinal transit. However, the promising biopharmaceutical benefits of liquid lipid formulations has not translated into widespread commercial success, due to their susceptibility to long term storage and in vivo precipitation issues. One strategy that has emerged to overcome such limitations, is to combine the solubilisation and dissolution enhancing properties of lipids with the stabilising effects of solid carrier materials. The development of intelligent hybrid drug formulations has presented new opportunities to harness the potential of emulsified lipids in optimising oral bioavailability for lipophilic therapeutics. Specific emphasis of this review is placed on the impact of solidification approaches and excipients on the biopharmaceutical performance of self-emulsifying lipids, with findings highlighting the key design considerations that should be implemented when developing hybrid lipid-based formulations.
Original languageEnglish
JournalAdvanced Drug Delivery Reviews
ISSN0169-409X
DOIs
Publication statusAccepted/In press - 2019

Cite this

Joyce, P., Dening, T. J., Meola, T. R., Schultz, H. B., Holm, R., Thomas, N., & Prestidge, C. A. (Accepted/In press). Solidification to improve the biopharmaceutical performance of SEDDS: Opportunities and challenges. Advanced Drug Delivery Reviews. https://doi.org/10.1016/j.addr.2018.11.006
Joyce, Paul ; Dening, Tahnee J ; Meola, Tahlia R ; Schultz, Hayley B ; Holm, René ; Thomas, Nicky ; Prestidge, Clive A. / Solidification to improve the biopharmaceutical performance of SEDDS : Opportunities and challenges. In: Advanced Drug Delivery Reviews. 2019.
@article{215a213380344400a58b5101df077faa,
title = "Solidification to improve the biopharmaceutical performance of SEDDS: Opportunities and challenges",
abstract = "Self-emulsifying drug delivery systems (SEDDS) offer potential for overcoming the inherent slow dissolution and poor oral absorption of hydrophobic drugs by retaining them in a solubilised state during gastrointestinal transit. However, the promising biopharmaceutical benefits of liquid lipid formulations has not translated into widespread commercial success, due to their susceptibility to long term storage and in vivo precipitation issues. One strategy that has emerged to overcome such limitations, is to combine the solubilisation and dissolution enhancing properties of lipids with the stabilising effects of solid carrier materials. The development of intelligent hybrid drug formulations has presented new opportunities to harness the potential of emulsified lipids in optimising oral bioavailability for lipophilic therapeutics. Specific emphasis of this review is placed on the impact of solidification approaches and excipients on the biopharmaceutical performance of self-emulsifying lipids, with findings highlighting the key design considerations that should be implemented when developing hybrid lipid-based formulations.",
author = "Paul Joyce and Dening, {Tahnee J} and Meola, {Tahlia R} and Schultz, {Hayley B} and Ren{\'e} Holm and Nicky Thomas and Prestidge, {Clive A.}",
year = "2019",
doi = "10.1016/j.addr.2018.11.006",
language = "English",
journal = "Advanced Drug Delivery Reviews",
issn = "0169-409X",
publisher = "Elsevier BV",

}

Solidification to improve the biopharmaceutical performance of SEDDS : Opportunities and challenges. / Joyce, Paul; Dening, Tahnee J; Meola, Tahlia R; Schultz, Hayley B; Holm, René; Thomas, Nicky; Prestidge, Clive A.

In: Advanced Drug Delivery Reviews, 2019.

Research output: Contribution to journalJournal articleResearchpeer-review

TY - JOUR

T1 - Solidification to improve the biopharmaceutical performance of SEDDS

T2 - Opportunities and challenges

AU - Joyce, Paul

AU - Dening, Tahnee J

AU - Meola, Tahlia R

AU - Schultz, Hayley B

AU - Holm, René

AU - Thomas, Nicky

AU - Prestidge, Clive A.

PY - 2019

Y1 - 2019

N2 - Self-emulsifying drug delivery systems (SEDDS) offer potential for overcoming the inherent slow dissolution and poor oral absorption of hydrophobic drugs by retaining them in a solubilised state during gastrointestinal transit. However, the promising biopharmaceutical benefits of liquid lipid formulations has not translated into widespread commercial success, due to their susceptibility to long term storage and in vivo precipitation issues. One strategy that has emerged to overcome such limitations, is to combine the solubilisation and dissolution enhancing properties of lipids with the stabilising effects of solid carrier materials. The development of intelligent hybrid drug formulations has presented new opportunities to harness the potential of emulsified lipids in optimising oral bioavailability for lipophilic therapeutics. Specific emphasis of this review is placed on the impact of solidification approaches and excipients on the biopharmaceutical performance of self-emulsifying lipids, with findings highlighting the key design considerations that should be implemented when developing hybrid lipid-based formulations.

AB - Self-emulsifying drug delivery systems (SEDDS) offer potential for overcoming the inherent slow dissolution and poor oral absorption of hydrophobic drugs by retaining them in a solubilised state during gastrointestinal transit. However, the promising biopharmaceutical benefits of liquid lipid formulations has not translated into widespread commercial success, due to their susceptibility to long term storage and in vivo precipitation issues. One strategy that has emerged to overcome such limitations, is to combine the solubilisation and dissolution enhancing properties of lipids with the stabilising effects of solid carrier materials. The development of intelligent hybrid drug formulations has presented new opportunities to harness the potential of emulsified lipids in optimising oral bioavailability for lipophilic therapeutics. Specific emphasis of this review is placed on the impact of solidification approaches and excipients on the biopharmaceutical performance of self-emulsifying lipids, with findings highlighting the key design considerations that should be implemented when developing hybrid lipid-based formulations.

U2 - 10.1016/j.addr.2018.11.006

DO - 10.1016/j.addr.2018.11.006

M3 - Journal article

JO - Advanced Drug Delivery Reviews

JF - Advanced Drug Delivery Reviews

SN - 0169-409X

ER -